A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I

M B Martin1, T F Franke, G E Stoica

  • 1Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC 20007, USA.

Endocrinology
|December 7, 2000
PubMed

Insights

The serine/threonine protein kinase, Akt, mediates cross-talk between growth factor receptors and estrogen receptor-alpha (ER-alpha). Akt activation by EGF and IGF-I influences ER-alpha expression and activity.

Area of Science:

  • Cellular Biology
  • Molecular Endocrinology
  • Signal Transduction

Background:

  • Cross-talk between growth factor signaling pathways and nuclear receptors is crucial for cellular regulation.
  • Epidermal growth factor (EGF) and insulin-related growth factor I (IGF-I) signaling pathways are known to influence estrogen receptor-alpha (ER-alpha) activity.
  • The role of serine/threonine protein kinase, Akt, in mediating this cross-talk requires further elucidation.

Purpose of the Study:

  • To investigate the involvement of Akt in the cross-talk between EGF/IGF-I receptors and ER-alpha.
  • To determine the downstream effects of Akt activation on ER-alpha expression and activity.
  • To identify specific mechanisms by which Akt modulates ER-alpha function.

Main Methods:

  • Treatment of MCF-7 cells with EGF or IGF-I and assessment of Akt phosphorylation and activity.
  • Use of phosphatidylinositol 3-kinase and p70S6K inhibitors to study Akt activation.
  • Stable transfection of cells with dominant-negative or constitutively active Akt mutants.
  • Coexpression studies in COS-1 cells with ER-alpha and Akt mutants.
  • Analysis of ER-alpha, progesterone receptor, and pS2 expression at protein and mRNA levels.
  • Site-directed mutagenesis of ER-alpha to identify key residues involved in Akt-mediated activation.

Main Results:

  • EGF and IGF-I treatment rapidly activated Akt in MCF-7 cells.
  • Akt activation was dependent on phosphatidylinositol 3-kinase but not p70S6K.
  • Dominant-negative Akt blocked EGF/IGF-I effects on ER-alpha, while constitutively active Akt mimicked them.
  • Constitutively active Akt decreased ER-alpha levels and increased progesterone receptor and pS2 levels.
  • Akt enhanced ER-alpha activity via the amino-terminal activation function-1 (AF-1), involving serines S104, S106, S118, and S167.

Conclusions:

  • Akt plays a critical role in mediating the cross-talk between EGF/IGF-I receptors and ER-alpha.
  • Akt activation by growth factors leads to modulation of ER-alpha expression and transcriptional activity.
  • Specific serine residues in ER-alpha are essential for Akt-mediated functional regulation.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Secondary Messengers in Hormone Action01:26

Secondary Messengers in Hormone Action

Water-soluble hormones cannot cross the plasma membrane, so they rely on protein receptors that span the membrane to trigger intracellular signaling pathways. These pathways then activate second messengers inside the cell, including cAMP or calcium ions.
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...